Navigation Links
China Sky One Medical, Inc. Qualifies for Preferential Income Tax Rate
Date:1/6/2009

nufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company (''TDR''), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical,
'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Health Robotics Announces Partnership in the Peoples Republic of China With The Devon International Group
2. China Sky One Medical, Inc. Receives Scientific Achievement Award
3. China Medicine to Distribute Dental and Surgical Instruments
4. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
5. VIASPACE Plants Biofuel & Animal Feed Grass and Signs Land Lease in China
6. China Sky One Medical, Inc. Interviewed in The China Perspective
7. China Medicine Corporation Awarded GSP Certification
8. NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors
9. China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
10. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
11. China Biologic Products Reports Strong Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):UAB bone center director wins distinguished service award from clinical pathology society 2H1N1 influenza adopted novel strategy to move from birds to humans 2H1N1 influenza adopted novel strategy to move from birds to humans 3H1N1 influenza adopted novel strategy to move from birds to humans 4Superior offspring without genetic modification 2Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 1Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 2Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 3Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 4Statement by John Bailey Chief Scientist The Personal Care Products Council Response to EWGs 2009 Sunscreen Report 50635 5Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute 50632 1Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute 50632 2Study Casts Doubt on Low IQs Role in Early Death 50630 1Study Casts Doubt on Low IQs Role in Early Death 50630 2